PRELUDE CAPITAL MANAGEMENT, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q2 2022$94,000
-28.8%
45,5000.0%0.00%
-25.0%
Q1 2022$132,000
-9.6%
45,5000.0%0.00%0.0%
Q4 2021$146,000
-9.3%
45,5000.0%0.00%0.0%
Q3 2021$161,000
+11.8%
45,5000.0%0.00%0.0%
Q2 2021$144,000
-16.3%
45,500
-9.0%
0.00%0.0%
Q1 2021$172,000
-31.7%
50,000
-50.0%
0.00%
-33.3%
Q4 2020$252,000
+19.4%
100,0000.0%0.01%
-40.0%
Q3 2020$211,000
+2537.5%
100,000
+6620.4%
0.01%
+900.0%
Q1 2018$8,000
-96.7%
1,488
-94.8%
0.00%
-95.7%
Q1 2017$241,000
+73.4%
28,800
+43.3%
0.02%
+35.3%
Q4 2016$139,000
+286.1%
20,100
+183.1%
0.02%
+325.0%
Q3 2016$36,000
-54.4%
7,100
-46.2%
0.00%
-63.6%
Q2 2016$79,000
+41.1%
13,200
+7.3%
0.01%
+37.5%
Q1 2016$56,000
-13.8%
12,300
-15.2%
0.01%
-20.0%
Q4 2015$65,000
-1.5%
14,500
-30.6%
0.01%0.0%
Q3 2015$66,000
+4.8%
20,9000.0%0.01%
+11.1%
Q2 2015$63,000
-14.9%
20,900
-17.1%
0.01%
-10.0%
Q1 2015$74,000
-43.9%
25,200
-15.2%
0.01%
-47.4%
Q4 2014$132,000
-9.6%
29,700
+4.9%
0.02%
-9.5%
Q3 2014$146,00028,3000.02%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders